Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,652,090 | 4,604,979 | 5,877,177 | 8,078,928 | 6,010,368 |
| Marketable Securities | 2,955,506 | 5,373,094 | 342,400 | 295,320 | 638,450 |
| Receivables | 9,650,176 | 9,224,800 | 11,476,580 | 9,787,933 | 9,530,781 |
| Inventories | 6,838,962 | 6,365,087 | 7,952,203 | 7,698,864 | 7,593,724 |
| Other current assets | 94,536 | 121,220 | 30,260 | 136,105 | 1,114,737 |
| TOTAL | $23,191,270 | $25,689,180 | $25,678,620 | $25,997,150 | $24,888,060 |
| Non-Current Assets | |||||
| PPE Net | 11,219,980 | 11,049,230 | 13,657,490 | 13,065,980 | 13,213,360 |
| Investments And Advances | 1,482,729 | 1,906,063 | 3,069,223 | 4,402,836 | 2,878,133 |
| Intangibles | 26,842,123 | 26,425,127 | 55,871,690 | 51,900,570 | 53,013,060 |
| Other Non-Current Assets | 10,660,218 | 9,324,990 | 10,497,507 | 7,906,864 | 7,766,107 |
| TOTAL | $50,205,050 | $48,705,410 | $83,095,910 | $77,276,250 | $76,870,660 |
| Total Assets | $73,396,320 | $74,394,590 | $108,774,500 | $103,273,400 | $101,758,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,499,091 | 4,888,229 | 4,951,735 | 4,782,900 | 8,833,594 |
| Accounts payable and accrued liabilities | 19,708,350 | 20,115,710 | 24,138,510 | 20,338,560 | 19,075,610 |
| Accrued Expenses | 621,950 | 582,580 | 672,424 | 699,780 | 803,170 |
| Other current liabilities | 2,377,093 | 2,627,176 | 2,785,953 | 2,616,792 | 1,997,072 |
| TOTAL | $26,206,480 | $28,213,690 | $32,548,620 | $28,438,030 | $30,709,450 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,913,500 | 21,070,590 | 28,288,560 | 30,077,700 | 30,122,070 |
| Other Non-Current Liabilities | 11,501,105 | 11,442,567 | 12,722,419 | 12,597,324 | 11,826,642 |
| TOTAL | $31,274,140 | $33,693,160 | $46,878,530 | $48,117,900 | $47,609,210 |
| Total Liabilities | $57,480,620 | $61,906,840 | $79,427,150 | $76,555,930 | $78,318,660 |
| Shareholders' Equity | |||||
| Common Shares | 1,676,777 | 1,666,104 | 1,852,260 | 1,728,264 | 1,718,707 |
| Retained earnings | 9,004,592 | 5,396,595 | 10,923,790 | 8,673,420 | 5,784,357 |
| Other shareholders' equity | 941,632 | 1,170,105 | 12,032,125 | 12,102,982 | 11,884,105 |
| TOTAL | $15,915,700 | $12,487,740 | $29,347,380 | $26,717,470 | $23,440,050 |
| Total Liabilities And Equity | $73,396,320 | $74,394,580 | $108,774,530 | $103,273,400 | $101,758,710 |